Loxoprofen

Phase 3Small molecule

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Loxoprofen is one of 131 small molecule programs targeting Respiratory tract infection. It is currently in Phase 3.

Indications

Total Trials

Active Trials

130

Competitors

Pipeline

Status by Indication[3][1]

Indication

Respiratory Tract InfectionActive, not recruiting

Low Back PainActive, not recruiting

Rheumatoid ArthritisActive, not recruiting

OsteoarthritisActive, not recruiting

Respiratory Tract InfectionPhase 3

Active, not recruiting

Low Back PainPhase 2

Active, not recruiting

Rheumatoid ArthritisPhase 2

Active, not recruiting

OsteoarthritisPhase 2

Active, not recruiting

Competition

Competitive Landscape

791 competitors in Rheumatoid Arthritis

#DrugCompanyPhaseTrials

Loxoprofen

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

1 2

Rituxan

Roche

Preclinical

61 3

Orencia

Bristol-Myers Squibb

Preclinical

47 4

Actemra

Simponi

19 6

Arcoxia

Novartis

Preclinical

4 7

Ilaris

Novartis

Preclinical

3 8

Actos

Takeda

Preclinical

2 9

Zelhou

Jiangsu Simcere Pharmaceutical Co., Ltd.

Preclinical

7 10

Kineret

SSwedish Orphan Biovitrum

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Low back pain2 trials

Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 3·NCT00141154·1,234 enrolled

Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain

Unknown status·KKyunghee University Medical Center·Phase 2·NCT01491321·54 enrolled

Interaction1 trial

Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males

Completed· AstraZeneca logo

AstraZeneca·Phase 1·NCT00676117·30 enrolled

Rheumatoid Arthritis1 trial

Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis

Completed·PPeking University People's Hospital·Phase 2·NCT02467504·47 enrolled

Celecoxib1 trial

Study Of Celecoxib In Healthy Subjects

Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 4·NCT00994461·190 enrolled

Osteoarthritis1 trial

A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis

Unknown status·JJiangsu HengRui Medicine Co., Ltd.·Phase 2·NCT06047483·90 enrolled

2 more indications

Respiratory tract infection1 trial

Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection

Completed· Daewon Pharmaceutical Co., Ltd. logo

Daewon Pharmaceutical Co., Ltd.·Phase 3·NCT01779271·183 enrolled

Acupuncture1 trial

East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia

Completed·KKyunghee University Medical Center·Phase 2·NCT01922466·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Loxoprofen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Loxoprofen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Loxoprofen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer's Upjohn has merged with Mylan to form Viatris Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Loxoprofen

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Low back pain2 trials

Interaction1 trial

Rheumatoid Arthritis1 trial

Celecoxib1 trial

Osteoarthritis1 trial

Respiratory tract infection1 trial

Acupuncture1 trial

References

Drug Info

Quick Facts

Related News